STOCK TITAN
  1. Home
  2. News
  3. TKNO

Alpha Teknova Inc - TKNO STOCK NEWS

Welcome to our dedicated news page for Alpha Teknova (Ticker: TKNO), a resource for investors and traders seeking the latest updates and insights on Alpha Teknova.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Alpha Teknova's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Alpha Teknova's position in the market.

News
Teknova Reports Fourth Quarter and Full Year 2023 Financial Results
Rhea-AI Summary
Alpha Teknova, Inc. (TKNO) reported a 11% decrease in total revenue for full year 2023, reaching $36.7 million. Despite this, the company achieved a 36% growth in Clinical Solutions customers. Teknova provided a revenue guidance of $35-38 million for 2024, with cost reduction measures in place to improve financial performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.63%
Tags
earnings
-
News
Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
Rhea-AI Summary
Alpha Teknova, Inc. (TKNO) will report its financial results for Q4 and full year 2023 on March 11, 2024. A webcast and conference call will be held at 5:30 p.m. Eastern Time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.33%
Tags
conferences earnings
-
News
Teknova Reports Third Quarter 2023 Financial Results
Rhea-AI Summary
Alpha Teknova, Inc. (Nasdaq: TKNO) raised $22.9 million of equity capital, paid down $10.0 million of long-term debt, and reported third quarter 2023 total revenue of $8.2 million, down 24% from prior year. Expect 2023 revenue at the low end of previously announced guidance range of $37-40 million. The company's President and CEO, Stephen Gunstream, highlighted the expansion of their GMP facility to produce various products to meet customer needs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.99%
Tags
earnings
News
Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023
Rhea-AI Summary
Alpha Teknova, Inc. will report its financial results for Q3 2023 on November 9, 2023. The webcast and conference call will be held at 5:30 p.m. Eastern Time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.15%
Tags
conferences earnings
-
News
Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development
Rhea-AI Summary
Alpha Teknova, Inc. launches AAV-Tek AEX Buffer Screening Kit for AAV6 and suite of reagents for plasmid production, supporting multiple AAV constructs and workflows. The kit helps identify ideal buffer formulation for downstream processing, saving developers months of process development time. Teknova offers over 60 off-the-shelf reagents for plasmid production. The AAV-Tek AEX Buffer Screening Kit for AAV6 is priced at $1,400. Teknova plans to release support for AAV5 and AAV9 in the future.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.82%
Tags
none
-
News
Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility
Rhea-AI Summary
Alpha Teknova, Inc. announced the closing of its direct offering and private placement, raising approximately $22.915 million. The proceeds will be used for general corporate purposes, including debt repayment. Concurrently, Teknova completed an amendment to its credit agreement, lowering covenants for minimum net revenue and minimum cash.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.03%
Tags
offering
News
Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement
Rhea-AI Summary
Alpha Teknova, Inc. announces definitive agreements for the issuance and sale of up to 1,086,485 shares of common stock in a registered direct offering and up to 11,299,993 shares of common stock in a private placement. The offerings are priced at $1.85 per share, expected to close on or about September 19, 2023, and expected to generate gross proceeds of up to approximately $22.915 million. The net proceeds will be used for general corporate purposes, including debt repayment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.24%
Tags
offering
-
News
Teknova Announces New Board Member, Martha J. Demski
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
management
-
News
Teknova Reports Second Quarter 2023 Financial Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
earnings
News
Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.88%
Tags
none
Stock TKNO logo
Alpha Teknova Inc

Nasdaq:TKNO

TKNO Rankings

#4513 Ranked by Market Cap
#4829 Ranked by Stock Gains
N/A Ranked by Dividends

TKNO Stock Data

98.38M
10.36M
11.43%
77.3%
0.12%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States
Hollister

About TKNO

teknova makes prepared media for bacteria and yeast applications. we have a full portfolio that includes plated and liquid growth media, as well as dry microbiological media that is available both bottled and in our propietary soluble pouch. we also have a full range of buffers, reagents and solutions, and everything we carry is available in custom formulations in order to optimize our products specifically to each of our customer's application. we have done it all before, and we challenge our customers to come up with a formulation that is a first time request.